Itxaso Garcia-Orue

Itxaso Garcia-Orue

Auto-generated profile, based on publicly available information

Itxaso Garcia-Orue

NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
IGItxaso Garcia-Orue
Itxaso Garcia-Orue
GGGarazi Gainza
Garazi Gainza
FGFranciso Borja Gutierrez
Franciso Borja Gutierrez
JAJose Javier Aguirre
Jose Javier Aguirre
CECarmen Evora
Carmen Evora
MIManoli Igartua
Manoli Igartua

1 November 2016 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
IGItxaso Garcia-Orue
Itxaso Garcia-Orue
GGGarazi Gainza
Garazi Gainza
CGCecilia Girbau
Cecilia Girbau
RARodrigo Alonso
Rodrigo Alonso
JAJosé Javier Aguirre
José Javier Aguirre
Rosa Maria HernandezRosa Maria Hernandez
Rosa Maria Hernandez

1 February 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
IGItxaso Garcia-Orue
Itxaso Garcia-Orue
GGGarazi Gainza
Garazi Gainza
PGPatricia García García
Patricia García García
FGFrancisco Borja Gutierrez
Francisco Borja Gutierrez
JAJose Javier Aguirre
Jose Javier Aguirre
MIManoli Igartua
Manoli Igartua

4 July 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
IGItxaso Garcia-Orue
Itxaso Garcia-Orue
EVEDORTA SANTOS VIZCAINO
EDORTA SANTOS VIZCAINO
AEAlaitz Etxabide
Alaitz Etxabide
JUJone Uranga
Jone Uranga
ABArdeshir Bayat
Ardeshir Bayat
Rosa Maria HernandezRosa Maria Hernandez
Rosa Maria Hernandez
In the current study, we developed a novel gelatin-based bilayer wound dressing. We used different crosslinking agents to confer unique properties to each layer, obtaining a bioinspired multifunctional hydrofilm suitable for wound healing. First, we produced a resistant and non-degradable upper layer by lactose-mediated crosslinking of gelatin, which provided mechanical support and protection to overall design. For the lower layer, we crosslinked gelatin with citric acid, resulting in a porous matrix with a great swelling ability. In addition, we incorporated chitosan into the lower layer to harness its wound healing ability. FTIR and SEM analyses showed that lactose addition changed the secondary structure of gelatin, leading to a more compact and smoother structure than that obtained with citric acid. The hydrofilm was able to swell 384.2 ± 57.2% of its dry weight while maintaining mechanical integrity. Besides, its water vapour transmission rate was in the range of commercial dressings (1381.5 ± 108.6 g/m2·day). In vitro, cytotoxicity assays revealed excellent biocompatibility. Finally, the hydrofilm was analysed through an ex vivo wound healing assay in human skin. It achieved similar results to the control in terms of biocompatibility and wound healing, showing suitable characteristics to be used as a wound dressing.

14 April 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
PMPaula Gabriela Manita
Paula Gabriela Manita
IGItxaso Garcia-Orue
Itxaso Garcia-Orue
EVEDORTA SANTOS VIZCAINO
EDORTA SANTOS VIZCAINO
Rosa Maria HernandezRosa Maria Hernandez
Rosa Maria Hernandez
MIManoli Igartua
Manoli Igartua
The aim of this review is to present 3D bioprinting of skin substitutes as an efficient approach of managing skin injuries. From a clinical point of view, classic treatments only provide physical protection from the environment, and existing engineered scaffolds, albeit acting as a physical support for cells, fail to overcome needs, such as neovascularisation. In the present work, the basic principles of bioprinting, together with the most popular approaches and choices of biomaterials for 3D-printed skin construct production, are explained, as well as the main advantages over other production methods. Moreover, the development of this technology is described in a chronological manner through examples of relevant experimental work in the last two decades: from the pioneers Lee et al. to the latest advances and different innovative strategies carried out lately to overcome the well-known challenges in tissue engineering of skin. In general, this technology has a huge potential to offer, although a multidisciplinary effort is required to optimise designs, biomaterials and production processes.

1 December 2017 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
IGItxaso Garcia-Orue
Itxaso Garcia-Orue
José Luis PedrazJosé Luis Pedraz
José Luis Pedraz
Rosa Maria HernandezRosa Maria Hernandez
Rosa Maria Hernandez
MIManoli Igartua
Manoli Igartua